Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Financial tracks

    H.C. Wainwright hired Ching-Yi Lin as a managing director in equity research and senior biotechnology analyst. She was a senior research associate at Stifel covering the pharmaceutical sector. Sofinnova Ventures hired …

    Published on 1/9/2015
  • FINANCIAL NEWS: PureTech raises another $50M

    PureTech Ventures (Boston, Mass.) raised $50 million from Invesco Perpetual and other existing investors. The firm raised $57 million in October 2014 in a separate round that included Invesco.The science and technology …

    Published on 1/9/2015
  • FINANCIAL NEWS: China's Hua Medicine raises $25M Series B

    Hua Medicine Ltd. (Shanghai, China) raised $25 million in a series B round led by Ally Bridge Group. New investors included Frontline BioVentures and TF Capital. Existing investors Arch Venture Partners; Venrock; …

    Published on 1/8/2015
  • FINANCIAL NEWS: Funding roundup: Alder, Avalanche, OvaScience, Stemline

    Four biotechs -- Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), Avalanche Biotechnologies Inc. (NASDAQ:AAVL), OvaScience Inc. (NASDAQ:OVAS) and Stemline Therapeutics Inc. (NASDAQ:STML) -- raised a total of $470.5 million …

    Published on 1/8/2015
  • FINANCIAL NEWS: Strategics join $35M A round for Surface Oncology

    Cancer immunotherapy play Surface Oncology Inc. (Cambridge, Mass.) raised $35 million in a series A round led by existing investor Atlas Venture. New investors Fidelity Biosciences; Lilly Ventures; New Enterprise …

    Published on 1/8/2015
  • FINANCIAL NEWS: Cancer play Blend raises $21M

    Cancer company Blend Therapeutics Inc. (Watertown, Mass.) raised $21 million through an undisclosed combination of equity and debt. The equity portion -- an extension of a series B round -- came from existing investors …

    Published on 1/7/2015
  • FINANCIAL NEWS: Follow-on roundup: Synageva, Five Prime, Cerus

    Shares of Synageva BioPharma Corp. (NASDAQ:GEVA), Five Prime Therapeutics Inc. (NASDAQ:FPRX) and Cerus Corp. (NASDAQ:CERS) all rose on Wednesday after the companies raised a total of $427.6 million in follow-ons.Rare …

    Published on 1/7/2015
  • FINANCIAL NEWS: Newco Vtesse raises $25M for Niemann-Pick therapies

    Vtesse Inc. (Gaithersburg, Md.) spun out of Orphan drug accelerator Cydan Development Inc. (Cambridge, Mass.) and raised $25 million in a series A round to study treatments for Niemann-Pick type C disease. New …

    Published on 1/7/2015
  • FINANCIAL NEWS: Global Blood raises $48M in series B

    Global Blood Therapeutics Inc. (South San Francisco, Calif.) raised $48 million in an untranched series B round from Wellington Management; RA Capital; Deerfield Management; Sabby Capital; Perceptive Life Sciences; an …

    Published on 1/6/2015
  • FINANCIAL NEWS: Nestle invests $65M in Seres' D round

    Microbiome company Seres Health Inc. (Cambridge, Mass.) closed a $65 million series D round from the Nestle Health Science subsidiary of Nestle SA (SIX:NESN). The investment comes one month after Seres' $48 million …

    Published on 1/6/2015
  • FINANCIAL NEWS: Aduro raises $51.4M in D round

    Aduro Biotech Inc. (Berkeley, Calif.) raised $51.4 million in a series D round. New investors included OrbiMed; Janus Capital Management; Franklin Advisers; Jennison Associates; Foresite Capital Management; Clough …

    Published on 1/5/2015
  • FINANCIAL NEWS: Chiasma raises $33.8M after Roche deal unwinds

    Chiasma Inc. (Jerusalem, Israel) raised $33.8 million out of a proposed $56.3 million financing round, according to a regulatory filing. The company said in October it would independently develop and commercialize oral …

    Published on 1/5/2015
  • FINANCIAL NEWS: 3-V Biosciences raises $28.5M series D

    3-V Biosciences Inc. (Menlo Park, Calif.) raised $28.5 million in a series D round co-led by New Enterprise Associates; Kleiner Perkins Caufield & Byers; and Rock Springs Capital Management. Ally Bridge Group and other …

    Published on 12/31/2014
  • FINANCIAL NEWS: CHOP hoping to Spark a happy New Year

    The Children's Hospital of Philadelphia (CHOP) owns 53.4% of the outstanding shares of Spark Therapeutics Inc. (Philadelphia, Pa.), according to the gene therapy company's IPO filing. The research hospital spun out …

    Published on 12/31/2014
  • FINANCIAL NEWS: Holiday notice

    BioCentury Extra will not publish on Thursday, Jan. 1, in observance of the New Year's Day holiday. BioCentury Extra will resume publishing on Friday, Jan. 2.

    Published on 12/31/2014
  • FINANCIAL NEWS: Inovalon files for IPO

    Inovalon Holdings Inc. (Bowie, Md.) filed to raise up to $500 million in an IPO on NASDAQ underwritten by Goldman Sachs; Morgan Stanley; Citigroup; BofA Merrill Lynch; UBS Investment Bank; Baird; Piper Jaffray; Wells …

    Published on 12/31/2014
  • FINANCIAL NEWS: Karolinska raises SEK347.9M

    Karolinska Development AB (SSE:KDEV) raised SEK347.9 million ($44.6 million) through the sale of convertible bonds that mature on Dec. 31, 2019, have an 8% annual interest rate and may be converted into series B shares …

    Published on 12/31/2014
  • FINANCIAL NEWS: Spark, HTG file for IPOs

    Spark Therapeutics Inc. (Philadelphia, Pa.) and HTG Molecular Diagnostics Inc. (Tucson, Ariz.) filed for IPOs on NASDAQ.Gene therapy play Spark filed to raise up to $86.3 million in an offering underwritten by JPMorgan;…

    Published on 12/30/2014
  • FINANCIAL NEWS: Conkwest raises $50 million

    Patrick Soon-Shiong's NantWorks LLC (Los Angeles, Calif.) made a $48 million equity investment in Conkwest Inc. (Cardiff-by-the-Sea, Calif.). Conkwest also named Soon-Shiong co-chairman of its board, alongside executive…

    Published on 12/29/2014
  • FINANCIAL NEWS: Flex Pharma files for IPO

    Neurology play Flex Pharma Inc. (Boston, Mass.) filed to raise up to $60 million in an IPO on NASDAQ underwritten by Jefferies; Piper Jaffray; JMP; Cantor Fitzgerald; and Roth Capital.Flex said it intends to start at …

    Published on 12/29/2014
  • FINANCIAL NEWS: Tracon files for IPO

    Tracon Pharmaceuticals Inc. (San Diego, Calif.) filed to raise up to $57.5 million in an IPO on NASDAQ underwritten by Wells Fargo; Stifel; Needham; and Oppenheimer.Tracon expects data in late 2015 to mid-2016 from four…

    Published on 12/29/2014
  • FINANCIAL NEWS: Vivo raises $427.7M for eighth fund

    Vivo Capital (formerly Vivo Ventures) raised $427.7 million for Vivo Capital Fund VIII, according to an SEC filing. The firm, which declined to comment on the news, invests primarily in late-stage development pharma and…

    Published on 12/29/2014
  • FINANCIAL NEWS: Alder proposes $115M follow-on

    After completing a downsized IPO in May, Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) is proposing to raise $115 million in a follow-on underwritten by Credit Suisse; Leerink; Wells Fargo; and Sanford Bernstein. The …

    Published on 12/23/2014
  • FINANCIAL NEWS: CardioDx withdraws IPO

    CardioDx Inc. (Palo Alto, Calif.) withdrew its IPO on NASDAQ, citing market conditions. In April, the company revived plans for an IPO it had postponed the previous fall, but it did not set terms (see BioCentury Extra, …

    Published on 12/23/2014
  • FINANCIAL NEWS: Financial tracks

    Sage Kelly resigned as managing director and global head of healthcare investment banking at Jefferies & Co. Inc. Laurence Reid is resigning as CBO of Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY), effective Dec. 31. He …

    Published on 12/19/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993